ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $660,995 | -22.8% | 197,312 | +10.9% | 0.01% | -33.3% |
| Q4 2022 | $855,757 | -14.5% | 177,912 | +1.2% | 0.01% | -18.2% |
| Q3 2022 | $1,001,000 | -19.0% | 175,873 | +1.1% | 0.01% | -8.3% |
| Q2 2022 | $1,236,000 | -5.5% | 174,043 | -3.9% | 0.01% | +9.1% |
| Q1 2022 | $1,308,000 | -12.7% | 181,135 | +8.0% | 0.01% | 0.0% |
| Q4 2021 | $1,499,000 | -74.5% | 167,686 | -0.0% | 0.01% | -76.1% |
| Q3 2021 | $5,880,000 | +77.4% | 167,701 | +8.7% | 0.05% | +64.3% |
| Q2 2021 | $3,314,000 | +32.9% | 154,266 | +282.1% | 0.03% | +21.7% |
| Q1 2021 | $2,493,000 | +80.8% | 40,375 | +22.3% | 0.02% | +76.9% |
| Q4 2020 | $1,379,000 | – | 33,010 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |